perioperative management of glp-1 agonists How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Patients on Glucagon-Like 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations

We're talking about sophisticated research compounds intended strictly for in-vitro and laboratory use

Very little downtime Rapid recovery Ideal Candidates If you have skin imperfections, unsightly spider veins, or unwanted hair, then you may be eligible for laser treatments at Beleza

the findings, however, were not statistically conclusive for the effects of this clinical trial on the incidence of postpartum depression (Slykerman et al., 2017)

Thus, clinical trials are needed to establish the benefits/risk profile in HF, considering that no properly designed, HF-specific randomised clinical trials have been completed with GLP-1 RAs in any of the HF phenotypes